Publication Information

{'id': 'https://openalex.org/W3123452764', 'doi': 'https://doi.org/10.1136/annrheumdis-2020-eular.949', 'title': 'FRI0335 THE EFFECT OF TOFACITINIB ON RESIDUAL PAIN IN PATIENTS WITH PSORIATIC ARTHRITIS', 'display_name': 'FRI0335 THE EFFECT OF TOFACITINIB ON RESIDUAL PAIN IN PATIENTS WITH PSORIATIC ARTHRITIS', 'publication_year': 2020, 'publication_date': '2020-06-01', 'ids': {'openalex': 'https://openalex.org/W3123452764', 'doi': 'https://doi.org/10.1136/annrheumdis-2020-eular.949', 'mag': '3123452764'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2020-eular.949', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/79/Suppl_1/760.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://ard.bmj.com/content/annrheumdis/79/Suppl_1/760.full.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5104491150', 'display_name': 'Maxime Dougados', 'orcid': 'https://orcid.org/0000-0003-3009-6229'}, 'institutions': [{'id': 'https://openalex.org/I4210092774', 'display_name': 'Hôpital Cochin', 'ror': 'https://ror.org/00ph8tk69', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210092774', 'https://openalex.org/I4210097159', 'https://openalex.org/I4210124464']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'M. Dougados', 'raw_affiliation_strings': ['Cochin Hospital, Paris, France'], 'affiliations': [{'raw_affiliation_string': 'Cochin Hospital, Paris, France', 'institution_ids': ['https://openalex.org/I4210092774']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5104506506', 'display_name': 'Désirée van der Heijde', 'orcid': 'https://orcid.org/0000-0002-5781-158X'}, 'institutions': [{'id': 'https://openalex.org/I2800006345', 'display_name': 'Leiden University Medical Center', 'ror': 'https://ror.org/05xvt9f17', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800006345']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'D. Van der Heijde', 'raw_affiliation_strings': ['Leiden University Medical Center, Leiden, Netherlands'], 'affiliations': [{'raw_affiliation_string': 'Leiden University Medical Center, Leiden, Netherlands', 'institution_ids': ['https://openalex.org/I2800006345']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5104520389', 'display_name': 'Clifton O. Bingham', 'orcid': 'https://orcid.org/0000-0002-4752-5029'}, 'institutions': [{'id': 'https://openalex.org/I145311948', 'display_name': 'Johns Hopkins University', 'ror': 'https://ror.org/00za53h95', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I145311948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'C. Bingham', 'raw_affiliation_strings': ['Johns Hopkins University, Baltimore, United States of America'], 'affiliations': [{'raw_affiliation_string': 'Johns Hopkins University, Baltimore, United States of America', 'institution_ids': ['https://openalex.org/I145311948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100700564', 'display_name': 'Peter C. Taylor', 'orcid': 'https://orcid.org/0000-0001-7766-6167'}, 'institutions': [{'id': 'https://openalex.org/I40120149', 'display_name': 'University of Oxford', 'ror': 'https://ror.org/052gg0110', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I40120149']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'P. C. Taylor', 'raw_affiliation_strings': ['University of Oxford, Oxford, United Kingdom'], 'affiliations': [{'raw_affiliation_string': 'University of Oxford, Oxford, United Kingdom', 'institution_ids': ['https://openalex.org/I40120149']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090182951', 'display_name': 'Lara Fallon', 'orcid': 'https://orcid.org/0000-0001-7113-1014'}, 'institutions': [{'id': 'https://openalex.org/I4210155296', 'display_name': 'Pfizer (Canada)', 'ror': 'https://ror.org/059g90c15', 'country_code': 'CA', 'type': 'company', 'lineage': ['https://openalex.org/I180857899', 'https://openalex.org/I4210155296']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'L. Fallon', 'raw_affiliation_strings': ['Pfizer Inc, Montreal, Canada'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Inc, Montreal, Canada', 'institution_ids': ['https://openalex.org/I4210155296']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009475149', 'display_name': 'John Woolcott', 'orcid': 'https://orcid.org/0000-0001-7445-8696'}, 'institutions': [{'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'J. Woolcott', 'raw_affiliation_strings': ['Pfizer Inc, Collegeville, United States of America'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Inc, Collegeville, United States of America', 'institution_ids': ['https://openalex.org/I180857899']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5068889905', 'display_name': 'Y. Brault', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210118061', 'display_name': 'Pfizer (France)', 'ror': 'https://ror.org/02c9yny10', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I180857899', 'https://openalex.org/I4210118061']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Y. Brault', 'raw_affiliation_strings': ['Pfizer Inc, Paris, France'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Inc, Paris, France', 'institution_ids': ['https://openalex.org/I4210118061']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076198331', 'display_name': 'L. Wang', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I180857899', 'display_name': 'Pfizer (United States)', 'ror': 'https://ror.org/01xdqrp08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I180857899']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'L. Wang', 'raw_affiliation_strings': ['Pfizer Inc, Groton, United States of America'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Inc, Groton, United States of America', 'institution_ids': ['https://openalex.org/I180857899']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5012389975', 'display_name': 'M. Kessouri', 'orcid': 'https://orcid.org/0000-0001-9967-3210'}, 'institutions': [{'id': 'https://openalex.org/I4210118061', 'display_name': 'Pfizer (France)', 'ror': 'https://ror.org/02c9yny10', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I180857899', 'https://openalex.org/I4210118061']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'M. Kessouri', 'raw_affiliation_strings': ['Pfizer Inc, Paris, France'], 'affiliations': [{'raw_affiliation_string': 'Pfizer Inc, Paris, France', 'institution_ids': ['https://openalex.org/I4210118061']}]}], 'institution_assertions': [], 'countries_distinct_count': 5, 'institutions_distinct_count': 7, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 7.389, 'has_fulltext': False, 'cited_by_count': 52, 'citation_normalized_percentile': {'value': 0.603289, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '79', 'issue': 'Suppl 1', 'first_page': '760', 'last_page': '761'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11616', 'display_name': 'Autoimmune and Inflammatory Disorders Research', 'score': 0.993, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11616', 'display_name': 'Autoimmune and Inflammatory Disorders Research', 'score': 0.993, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9844, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11092', 'display_name': 'Spondyloarthritis Studies and Treatments', 'score': 0.9819, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/janus-kinase-inhibitor', 'display_name': 'Janus kinase inhibitor', 'score': 0.7481786}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9570255}, {'id': 'https://openalex.org/C2778886723', 'wikidata': 'https://www.wikidata.org/wiki/Q3530324', 'display_name': 'Tofacitinib', 'level': 3, 'score': 0.9544343}, {'id': 'https://openalex.org/C2776233030', 'wikidata': 'https://www.wikidata.org/wiki/Q17149812', 'display_name': 'Janus kinase inhibitor', 'level': 4, 'score': 0.7481786}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.69447285}, {'id': 'https://openalex.org/C2780132546', 'wikidata': 'https://www.wikidata.org/wiki/Q348260', 'display_name': 'Adalimumab', 'level': 3, 'score': 0.6199062}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5327245}, {'id': 'https://openalex.org/C14184104', 'wikidata': 'https://www.wikidata.org/wiki/Q1362526', 'display_name': 'Visual analogue scale', 'level': 2, 'score': 0.43925518}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.3642845}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.28965557}, {'id': 'https://openalex.org/C2777575956', 'wikidata': 'https://www.wikidata.org/wiki/Q187255', 'display_name': 'Rheumatoid arthritis', 'level': 2, 'score': 0.19470328}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.04811284}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2020-eular.949', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/79/Suppl_1/760.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2020-eular.949', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/79/Suppl_1/760.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.71}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3215206800', 'https://openalex.org/W3137618193', 'https://openalex.org/W2915214480', 'https://openalex.org/W2905252141', 'https://openalex.org/W2896488923', 'https://openalex.org/W2752345645', 'https://openalex.org/W2248533790', 'https://openalex.org/W2113082323', 'https://openalex.org/W2018514505', 'https://openalex.org/W1778620981'], 'abstract_inverted_index': {'Background:': [0], 'Current': [1], 'treatments': [2], 'for': [3, 26], 'PsA': [4, 49, 213, 365], 'have': [5, 191, 374, 428], 'proven': [6], 'effective': [7], 'in': [8, 46, 80, 127, 169, 195, 262, 300, 309, 345, 353, 362, 430], 'reducing': [9], 'patient': [10], '(pt)-reported': [11], 'pain;': [12], '1,2': [13], 'however,': [14], 'residual': [15, 44, 176, 327, 378, 411], 'pain': [16, 45, 122, 126, 170, 177, 179, 258, 301, 323, 328, 344, 354, 357, 379], 'often': [17], 'remains.': [18], 'Tofacitinib': [19], 'is': [20], 'an': [21, 375], 'oral': [22], 'Janus': [23], 'kinase': [24], 'inhibitor': [25], 'the': [27, 36, 196, 386, 404], 'treatment': [28, 204, 332, 347], 'of': [29, 38, 57, 76, 132, 143, 217, 246, 291, 469, 478, 550], 'PsA.': [30, 83], 'Objectives:': [31], 'This': [32, 111], 'descriptive': [33], 'analysis': [34, 112], 'evaluated': [35], 'effect': [37, 376], 'tofacitinib,': [39], 'adalimumab': [40, 100], 'and': [41, 145, 175, 187, 199, 219, 239, 248, 282, 293, 355, 391, 401, 472, 491, 502, 513, 574, 577, 585, 596], 'placebo': [42, 253, 283, 316], 'on': [43, 377], 'pts': [47, 81, 114, 128, 211, 241, 264, 279, 287, 310, 363, 423], 'with': [48, 82, 115, 129, 212, 364, 424], 'whose': [50, 366], 'inflammation': [51, 133, 367], 'was': [52, 123, 151, 329, 389, 464], 'attenuated': [53], 'after': [54], '3': [55, 74, 84, 206], 'months': [56], 'therapy.': [58], 'Methods:': [59], 'Data': [60], 'were': [61, 86, 183, 200, 393], 'included': [62], 'from': [63, 171, 302, 335, 351, 422], 'OPAL': [64], 'Broaden': [65], '(': [66], 'NCT01877668': [67], '),': [68], 'a': [69, 138, 154, 341, 413], 'randomised,': [70], 'double-blind,': [71], 'placebo-controlled': [72], 'Phase': [73], 'trial': [75], '12': [77], 'months’': [78], 'duration': [79], 'Pts': [85], 'randomised': [87, 432], 'to': [88, 173, 304, 383, 402], 'receive': [89], 'tofacitinib': [90, 96, 233, 271, 312, 346, 372, 408, 431], '5': [91, 228, 266], 'mg': [92, 98, 102, 229, 235, 267, 273], 'twice': [93], 'daily': [94], '(BID),': [95], '10': [97, 234, 272], 'BID,': [99, 230, 236, 268, 274], '40': [101], 'subcutaneous': [103], 'injection': [104], 'once': [105], 'every': [106], '2': [107], 'weeks': [108], 'or': [109], 'placebo.': [110], 'assessed': [113], '‘residual': [116], 'pain’': [117], 'at': [118, 134, 181, 297, 324, 358], 'Month': [119], '(M)3.': [120], 'Residual': [121], 'considered': [124], 'as': [125], 'complete': [130], 'attenuation': [131], 'M3,': [135, 208, 224, 298, 325], 'defined': [136], 'by': [137, 153, 406, 458, 466, 474], 'swollen': [139], 'joint': [140], 'count': [141], '(SJC)': [142], '0': [144, 159, 218, 247, 292], 'CRP': [146, 220, 249, 294], 'levels': [147], '<6': [148, 221, 250, 295], 'mg/L.': [149, 222], 'Pain': [150], 'measured': [152], 'visual': [155], 'analogue': [156], 'scale': [157], '(VAS;': [158], '[“no': [160], 'pain”]': [161], '–': [162], '100': [163], 'mm': [164], '[“most': [165], 'severe': [166], 'pain”]).': [167], 'Changes': [168, 350], 'baseline': [172, 188, 303, 343, 352], 'M3': [174, 305, 359], '(VAS': [178], 'reported': [180, 194], 'M3)': [182], 'assessed.': [184], 'Results:': [185], 'Demographics': [186], 'disease': [189, 426], 'characteristics': [190], 'previously': [192], 'been': [193, 369], 'primary': [197], 'study,': [198], 'generally': [201], 'similar': [202, 330], 'between': [203], 'groups.': [205, 348], 'At': [207, 223], '100/422': [209], '(23.7%)': [210], 'had': [214], 'achieved': [215, 244, 289], 'SJC': [216, 245, 290], 'more': [225], 'tofacitinib-treated': [226, 263], '(tofacitinib': [227, 265], 'n=23/107': [231], '[21.5%];': [232], 'n=33/104': [237], '[31.7%])': [238], 'adalimumab-treated': [240, 278], '(n=31/106': [242], '[29.2%])': [243], 'mg/L': [251, 296], 'vs': [252, 277, 313], '(PsA:': [254], 'n=13/105': [255], '[12.4%]).': [256], 'Baseline': [257], 'appeared': [259, 306], 'numerically': [260, 307], 'higher': [261, 342], '54.7': [269], 'mm;': [270, 337], '58.4': [275], 'mm)': [276, 281], '(47.7': [280], '(50.4': [284], 'mm).': [285], 'In': [286], 'who': [288, 427], 'improvements': [299], 'greater': [308], 'receiving': [311, 315], 'those': [314], '(Figure': [317], '1a).': [318], 'When': [319], 'considering': [320], 'absolute': [321, 356], '(residual)': [322], 'mean': [326], 'across': [331], 'groups': [333], '(ranging': [334], '22.7–29.2': [336], 'Figure': [338], '1b),': [339], 'despite': [340], 'Conclusion:': [349], 'suggest': [360], 'that': [361], 'has': [368], 'completely': [370], 'attenuated,': [371], 'might': [373], 'not': [380], 'obviously': [381], 'attributable': [382], 'inflammation.': [384], 'However,': [385], 'sample': [387], 'population': [388], 'small,': [390], 'there': [392], 'large': [394], 'standard': [395], 'deviations.': [396], 'To': [397], 'confirm': [398], 'these': [399], 'results': [400], 'understand': [403], 'mechanisms': [405], 'which': [407], 'may': [409], 'improve': [410], 'pain,': [412], 'meta-analysis': [414], 'will': [415], 'be': [416], 'performed': [417], 'using': [418], 'individual': [419], 'participant': [420], 'data': [421], 'rheumatic': [425], 'participated': [429], 'controlled': [433], 'trials.': [434], 'References:': [435], '[1]Gladman': [436], 'et': [437, 444, 451], 'al.': [438, 445, 452], 'Ann': [439], 'Rheum': [440], 'Dis': [441], '2007;66:163-68.': [442], '[2]Gladman': [443], 'Arthritis': [446], 'Care': [447], 'Res': [448], '2014;66:1085-92.': [449], '[3]Mease': [450], 'NEJM': [453], '2017;377:1537-50.': [454], 'Acknowledgments:': [455], 'Study': [456], 'sponsored': [457], 'Pfizer': [459, 475, 490, 501, 512, 594, 602, 606, 612, 616, 622, 626, 632, 636, 642, 646], 'Inc.': [460, 476], 'Medical': [461], 'writing': [462], 'support': [463, 483, 557, 569], 'provided': [465], 'Mark': [467], 'Bennett': [468], 'CMC': [470], 'Connect': [471], 'funded': [473], 'Disclosure': [477], 'Interests:': [479], 'Maxime': [480], 'Dougados': [481], 'Grant/research': [482, 556, 568], 'from:': [484, 558, 570], 'AbbVie,': [485, 496, 507, 522, 581], 'Eli': [486, 497, 508, 572, 583], 'Lilly,': [487, 498, 509], 'Merck,': [488, 499, 510, 540], 'Novartis,': [489, 500, 511, 541], 'UCB': [492, 503, 514, 547], 'Pharma,': [493, 504, 515, 593], 'Consultant': [494, 520, 561, 579], 'of:': [495, 521, 562, 580, 601, 605, 611, 615, 621, 625, 631, 635, 641, 645], 'Speakers': [505], 'bureau:': [506], 'Désirée': [516], 'van': [517], 'der': [518], 'Heijde': [519], 'Amgen,': [523], 'Astellas,': [524], 'AstraZeneca,': [525], 'BMS,': [526], 'Boehringer': [527], 'Ingelheim,': [528], 'Celgene,': [529, 571], 'Cyxone,': [530], 'Daiichi,': [531], 'Eisai,': [532], 'Eli-Lilly,': [533], 'Galapagos,': [534, 576, 588], 'Gilead': [535], 'Sciences,': [536], 'Inc.,': [537], 'Glaxo-Smith-Kline,': [538], 'Janssen,': [539, 591], 'Pfizer,': [542], 'Regeneron,': [543], 'Roche,': [544, 595], 'Sanofi,': [545], 'Takeda,': [546], 'Pharma;': [548], 'Director': [549], 'Imaging': [551], 'Rheumatology': [552], 'BV,': [553], 'Clifton': [554], 'Bingham': [555], 'Bristol-Myers': [559, 563], 'Squibb,': [560, 564], 'Peter': [565], 'C.': [566], 'Taylor': [567], 'Lilly': [573, 584], 'Company,': [575, 586], 'Gilead,': [578, 589], 'Biogen,': [582], 'Fresenius,': [587], 'GlaxoSmithKline,': [590], 'Nordic': [592], 'UCB,': [597], 'Lara': [598], 'Fallon': [599], 'Shareholder': [600, 610, 620, 630, 640], 'Inc,': [603, 607, 613, 617, 633, 637], 'Employee': [604, 614, 624, 634, 644], 'John': [608], 'Woolcott': [609], 'Yves': [618], 'Brault': [619], 'France,': [623, 627, 643], 'Lisy': [628], 'Wang': [629], 'Meriem': [638], 'Kessouri': [639], 'France': [647]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3123452764', 'counts_by_year': [{'year': 2021, 'cited_by_count': 31}, {'year': 2020, 'cited_by_count': 21}], 'updated_date': '2024-12-12T18:04:11.143088', 'created_date': '2021-02-01'}